Mimedx (MDXG) Other Working Capital Changes (2011 - 2026)
Mimedx (MDXG) posted Other Working Capital Changes of $104000.0 for Q2 2026, down 11.86% sequentially from $118000.0 in Q1 2026, and down 18.75% YoY from $128000.0 in Q2 2025.
Mimedx (MDXG) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Mimedx has reported Other Working Capital Changes for 4 years, with the latest figure at $104000.0 in Q2 2026.
- Quarterly Other Working Capital Changes fell 18.75% year-over-year to $104000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $569000.0 (down 36.71% YoY) and the FY2025 annual result came in at $641000.0, down 42.36% from the prior year.
- Other Working Capital Changes slipped to $104000.0 in Q2 2026 per MDXG's latest filing, from $118000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.6 million in Q3 2025 and troughed at -$2.0 million in Q1 2026.
- A 5-year average of $276055.6 and a median of $82000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 325.57% in 2024, down 79.56% in 2024.
- Over 4 years, Other Working Capital Changes stood at $543000.0 in 2023, then plunged by 79.56% to $111000.0 in 2024, then decreased by 11.71% to $98000.0 in 2025, then rose by 6.12% to $104000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $104000.0, $118000.0, and $98000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.27 Mn |
| Jun 30, 2026 | -1.27 Mn |
| Jun 30, 2026 | -1.27 Mn |
| Mar 31, 2026 | -2.01 Mn |
| Mar 31, 2026 | -2.01 Mn |
| Mar 31, 2026 | -2.01 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -169,000.00 |
| Dec 31, 2024 | -169,000.00 |